nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Thiotepa—sarcoma	0.0765	0.458	CbGbCtD
Bexarotene—CYP3A4—Mitoxantrone—sarcoma	0.0329	0.197	CbGbCtD
Bexarotene—CYP3A4—Vincristine—sarcoma	0.0226	0.136	CbGbCtD
Bexarotene—CYP3A4—Etoposide—sarcoma	0.0208	0.124	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—sarcoma	0.0142	0.0847	CbGbCtD
Bexarotene—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000566	0.00068	CcSEcCtD
Bexarotene—Bronchitis—Epirubicin—sarcoma	0.000565	0.000678	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—sarcoma	0.000563	0.000676	CcSEcCtD
Bexarotene—Pancytopenia—Epirubicin—sarcoma	0.000558	0.00067	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000555	0.000666	CcSEcCtD
Bexarotene—Muscular weakness—Doxorubicin—sarcoma	0.000555	0.000666	CcSEcCtD
Bexarotene—Dysuria—Epirubicin—sarcoma	0.000549	0.000659	CcSEcCtD
Bexarotene—Neutropenia—Epirubicin—sarcoma	0.000549	0.000659	CcSEcCtD
Bexarotene—Dizziness—Thiotepa—sarcoma	0.000548	0.000658	CcSEcCtD
Bexarotene—Abdominal distension—Doxorubicin—sarcoma	0.000547	0.000657	CcSEcCtD
Bexarotene—Influenza—Doxorubicin—sarcoma	0.000543	0.000652	CcSEcCtD
Bexarotene—Dysphagia—Doxorubicin—sarcoma	0.000543	0.000652	CcSEcCtD
Bexarotene—Pollakiuria—Epirubicin—sarcoma	0.000543	0.000651	CcSEcCtD
Bexarotene—Hypersensitivity—Vincristine—sarcoma	0.000542	0.000651	CcSEcCtD
Bexarotene—Eosinophilia—Doxorubicin—sarcoma	0.000538	0.000646	CcSEcCtD
Bexarotene—Photosensitivity reaction—Epirubicin—sarcoma	0.000536	0.000644	CcSEcCtD
Bexarotene—Paraesthesia—Etoposide—sarcoma	0.000535	0.000642	CcSEcCtD
Bexarotene—Weight increased—Epirubicin—sarcoma	0.000534	0.000642	CcSEcCtD
Bexarotene—Pancreatitis—Doxorubicin—sarcoma	0.000533	0.00064	CcSEcCtD
Bexarotene—Weight decreased—Epirubicin—sarcoma	0.000531	0.000638	CcSEcCtD
Bexarotene—Dyspnoea—Etoposide—sarcoma	0.000531	0.000638	CcSEcCtD
Bexarotene—Hyperglycaemia—Epirubicin—sarcoma	0.00053	0.000636	CcSEcCtD
Bexarotene—Somnolence—Etoposide—sarcoma	0.00053	0.000636	CcSEcCtD
Bexarotene—Angina pectoris—Doxorubicin—sarcoma	0.000529	0.000635	CcSEcCtD
Bexarotene—Hypersensitivity—Mitoxantrone—sarcoma	0.000528	0.000634	CcSEcCtD
Bexarotene—Asthenia—Vincristine—sarcoma	0.000528	0.000634	CcSEcCtD
Bexarotene—Vomiting—Thiotepa—sarcoma	0.000527	0.000633	CcSEcCtD
Bexarotene—Pneumonia—Epirubicin—sarcoma	0.000527	0.000632	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—sarcoma	0.000523	0.000628	CcSEcCtD
Bexarotene—Rash—Thiotepa—sarcoma	0.000523	0.000628	CcSEcCtD
Bexarotene—Bronchitis—Doxorubicin—sarcoma	0.000523	0.000627	CcSEcCtD
Bexarotene—Dermatitis—Thiotepa—sarcoma	0.000522	0.000627	CcSEcCtD
Bexarotene—Headache—Thiotepa—sarcoma	0.00052	0.000624	CcSEcCtD
Bexarotene—Rash—Dactinomycin—sarcoma	0.000519	0.000623	CcSEcCtD
Bexarotene—Decreased appetite—Etoposide—sarcoma	0.000518	0.000622	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—sarcoma	0.000516	0.00062	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Etoposide—sarcoma	0.000514	0.000618	CcSEcCtD
Bexarotene—Asthenia—Mitoxantrone—sarcoma	0.000514	0.000617	CcSEcCtD
Bexarotene—Fatigue—Etoposide—sarcoma	0.000514	0.000617	CcSEcCtD
Bexarotene—Neuropathy peripheral—Epirubicin—sarcoma	0.000513	0.000616	CcSEcCtD
Bexarotene—Jaundice—Epirubicin—sarcoma	0.00051	0.000613	CcSEcCtD
Bexarotene—Stomatitis—Epirubicin—sarcoma	0.00051	0.000613	CcSEcCtD
Bexarotene—Constipation—Etoposide—sarcoma	0.00051	0.000612	CcSEcCtD
Bexarotene—Pain—Etoposide—sarcoma	0.00051	0.000612	CcSEcCtD
Bexarotene—Urinary tract infection—Epirubicin—sarcoma	0.000509	0.000611	CcSEcCtD
Bexarotene—Conjunctivitis—Epirubicin—sarcoma	0.000509	0.000611	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—sarcoma	0.000508	0.00061	CcSEcCtD
Bexarotene—Dysuria—Doxorubicin—sarcoma	0.000508	0.00061	CcSEcCtD
Bexarotene—Diarrhoea—Vincristine—sarcoma	0.000503	0.000604	CcSEcCtD
Bexarotene—Sweating—Epirubicin—sarcoma	0.000502	0.000603	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—sarcoma	0.000502	0.000603	CcSEcCtD
Bexarotene—Haematuria—Epirubicin—sarcoma	0.000499	0.000599	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—sarcoma	0.000496	0.000595	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—sarcoma	0.000495	0.000594	CcSEcCtD
Bexarotene—Epistaxis—Epirubicin—sarcoma	0.000494	0.000593	CcSEcCtD
Bexarotene—Nausea—Thiotepa—sarcoma	0.000493	0.000591	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—sarcoma	0.000492	0.00059	CcSEcCtD
Bexarotene—Sinusitis—Epirubicin—sarcoma	0.000491	0.00059	CcSEcCtD
Bexarotene—Feeling abnormal—Etoposide—sarcoma	0.000491	0.000589	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—sarcoma	0.00049	0.000588	CcSEcCtD
Bexarotene—Diarrhoea—Mitoxantrone—sarcoma	0.00049	0.000588	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—sarcoma	0.000489	0.000587	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—sarcoma	0.000487	0.000585	CcSEcCtD
Bexarotene—Gastrointestinal pain—Etoposide—sarcoma	0.000487	0.000585	CcSEcCtD
Bexarotene—Dizziness—Vincristine—sarcoma	0.000486	0.000584	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—sarcoma	0.000475	0.00057	CcSEcCtD
Bexarotene—Haemoglobin—Epirubicin—sarcoma	0.000472	0.000567	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—sarcoma	0.000472	0.000567	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—sarcoma	0.000472	0.000567	CcSEcCtD
Bexarotene—Rhinitis—Epirubicin—sarcoma	0.000471	0.000566	CcSEcCtD
Bexarotene—Body temperature increased—Etoposide—sarcoma	0.000471	0.000565	CcSEcCtD
Bexarotene—Abdominal pain—Etoposide—sarcoma	0.000471	0.000565	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—sarcoma	0.000471	0.000565	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—sarcoma	0.000471	0.000565	CcSEcCtD
Bexarotene—Haemorrhage—Epirubicin—sarcoma	0.00047	0.000564	CcSEcCtD
Bexarotene—Hypoaesthesia—Epirubicin—sarcoma	0.000468	0.000562	CcSEcCtD
Bexarotene—Vomiting—Vincristine—sarcoma	0.000468	0.000561	CcSEcCtD
Bexarotene—Pharyngitis—Epirubicin—sarcoma	0.000467	0.00056	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—sarcoma	0.000465	0.000558	CcSEcCtD
Bexarotene—Urinary tract disorder—Epirubicin—sarcoma	0.000464	0.000557	CcSEcCtD
Bexarotene—Rash—Vincristine—sarcoma	0.000464	0.000557	CcSEcCtD
Bexarotene—Dermatitis—Vincristine—sarcoma	0.000463	0.000556	CcSEcCtD
Bexarotene—Oedema peripheral—Epirubicin—sarcoma	0.000463	0.000556	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—sarcoma	0.000462	0.000555	CcSEcCtD
Bexarotene—Connective tissue disorder—Epirubicin—sarcoma	0.000462	0.000555	CcSEcCtD
Bexarotene—Urethral disorder—Epirubicin—sarcoma	0.000461	0.000553	CcSEcCtD
Bexarotene—Headache—Vincristine—sarcoma	0.000461	0.000553	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—sarcoma	0.000457	0.000549	CcSEcCtD
Bexarotene—Vomiting—Mitoxantrone—sarcoma	0.000455	0.000547	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—sarcoma	0.000455	0.000546	CcSEcCtD
Bexarotene—Rash—Mitoxantrone—sarcoma	0.000452	0.000542	CcSEcCtD
Bexarotene—Dermatitis—Mitoxantrone—sarcoma	0.000451	0.000542	CcSEcCtD
Bexarotene—Headache—Mitoxantrone—sarcoma	0.000449	0.000539	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—sarcoma	0.000439	0.000527	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—sarcoma	0.000439	0.000527	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—sarcoma	0.000438	0.000526	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—sarcoma	0.000437	0.000525	CcSEcCtD
Bexarotene—Nausea—Vincristine—sarcoma	0.000437	0.000524	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—sarcoma	0.000436	0.000524	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—sarcoma	0.000436	0.000524	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—sarcoma	0.000435	0.000522	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—sarcoma	0.000433	0.00052	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—sarcoma	0.000432	0.000518	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—sarcoma	0.00043	0.000516	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—sarcoma	0.000428	0.000514	CcSEcCtD
Bexarotene—Asthenia—Etoposide—sarcoma	0.000427	0.000513	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—sarcoma	0.000427	0.000513	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—sarcoma	0.000427	0.000512	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—sarcoma	0.000426	0.000512	CcSEcCtD
Bexarotene—Nausea—Mitoxantrone—sarcoma	0.000425	0.000511	CcSEcCtD
Bexarotene—Chills—Epirubicin—sarcoma	0.000422	0.000506	CcSEcCtD
Bexarotene—Pruritus—Etoposide—sarcoma	0.000422	0.000506	CcSEcCtD
Bexarotene—Arrhythmia—Epirubicin—sarcoma	0.00042	0.000504	CcSEcCtD
Bexarotene—Alopecia—Epirubicin—sarcoma	0.000415	0.000499	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—sarcoma	0.000409	0.000491	CcSEcCtD
Bexarotene—Erythema—Epirubicin—sarcoma	0.000409	0.000491	CcSEcCtD
Bexarotene—Diarrhoea—Etoposide—sarcoma	0.000408	0.000489	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—sarcoma	0.000406	0.000488	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—sarcoma	0.000406	0.000487	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—sarcoma	0.000404	0.000485	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—sarcoma	0.000403	0.000484	CcSEcCtD
Bexarotene—Tension—Epirubicin—sarcoma	0.000402	0.000482	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—sarcoma	0.000401	0.000481	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—sarcoma	0.000397	0.000477	CcSEcCtD
Bexarotene—Back pain—Epirubicin—sarcoma	0.000396	0.000475	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—sarcoma	0.000395	0.000474	CcSEcCtD
Bexarotene—Dizziness—Etoposide—sarcoma	0.000394	0.000473	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—sarcoma	0.000393	0.000472	CcSEcCtD
Bexarotene—Chills—Doxorubicin—sarcoma	0.00039	0.000469	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—sarcoma	0.000389	0.000466	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—sarcoma	0.000384	0.000461	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—sarcoma	0.00038	0.000456	CcSEcCtD
Bexarotene—Vomiting—Etoposide—sarcoma	0.000379	0.000455	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—sarcoma	0.000379	0.000455	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—sarcoma	0.000379	0.000455	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—sarcoma	0.000378	0.000454	CcSEcCtD
Bexarotene—Agitation—Epirubicin—sarcoma	0.000376	0.000451	CcSEcCtD
Bexarotene—Rash—Etoposide—sarcoma	0.000376	0.000451	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—sarcoma	0.000375	0.000451	CcSEcCtD
Bexarotene—Headache—Etoposide—sarcoma	0.000373	0.000448	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—sarcoma	0.000373	0.000448	CcSEcCtD
Bexarotene—Tension—Doxorubicin—sarcoma	0.000372	0.000446	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—sarcoma	0.000371	0.000445	CcSEcCtD
Bexarotene—Malaise—Epirubicin—sarcoma	0.000369	0.000443	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—sarcoma	0.000368	0.000442	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—sarcoma	0.000368	0.000441	CcSEcCtD
Bexarotene—Syncope—Epirubicin—sarcoma	0.000367	0.000441	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—sarcoma	0.000366	0.00044	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—sarcoma	0.000366	0.00044	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—sarcoma	0.000364	0.000437	CcSEcCtD
Bexarotene—Palpitations—Epirubicin—sarcoma	0.000362	0.000434	CcSEcCtD
Bexarotene—Loss of consciousness—Epirubicin—sarcoma	0.00036	0.000432	CcSEcCtD
Bexarotene—Cough—Epirubicin—sarcoma	0.000357	0.000429	CcSEcCtD
Bexarotene—Nausea—Etoposide—sarcoma	0.000354	0.000425	CcSEcCtD
Bexarotene—Hypertension—Epirubicin—sarcoma	0.000353	0.000424	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—sarcoma	0.000351	0.000422	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—sarcoma	0.00035	0.00042	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—sarcoma	0.000348	0.000418	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—sarcoma	0.000348	0.000418	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—sarcoma	0.000348	0.000418	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—sarcoma	0.000348	0.000418	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—sarcoma	0.000347	0.000417	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000346	0.000415	CcSEcCtD
Bexarotene—Discomfort—Epirubicin—sarcoma	0.000344	0.000413	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—sarcoma	0.000341	0.00041	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—sarcoma	0.000341	0.000409	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—sarcoma	0.00034	0.000408	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—sarcoma	0.00034	0.000408	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—sarcoma	0.000339	0.000407	CcSEcCtD
Bexarotene—Confusional state—Epirubicin—sarcoma	0.000337	0.000404	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—sarcoma	0.000335	0.000402	CcSEcCtD
Bexarotene—Oedema—Epirubicin—sarcoma	0.000334	0.000401	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—sarcoma	0.000333	0.0004	CcSEcCtD
Bexarotene—Infection—Epirubicin—sarcoma	0.000332	0.000398	CcSEcCtD
Bexarotene—Cough—Doxorubicin—sarcoma	0.00033	0.000397	CcSEcCtD
Bexarotene—Shock—Epirubicin—sarcoma	0.000329	0.000394	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—sarcoma	0.000328	0.000393	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—sarcoma	0.000327	0.000393	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—sarcoma	0.000327	0.000392	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—sarcoma	0.000326	0.000391	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—sarcoma	0.000324	0.000389	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—sarcoma	0.000323	0.000388	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—sarcoma	0.000322	0.000387	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—sarcoma	0.000322	0.000387	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—sarcoma	0.000322	0.000387	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—sarcoma	0.000321	0.000386	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00032	0.000384	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—sarcoma	0.000318	0.000382	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—sarcoma	0.000318	0.000382	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—sarcoma	0.000315	0.000378	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—sarcoma	0.000312	0.000374	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—sarcoma	0.000309	0.000371	CcSEcCtD
Bexarotene—Infection—Doxorubicin—sarcoma	0.000307	0.000369	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000304	0.000365	CcSEcCtD
Bexarotene—Shock—Doxorubicin—sarcoma	0.000304	0.000365	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—sarcoma	0.000303	0.000364	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—sarcoma	0.000303	0.000363	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—sarcoma	0.000302	0.000363	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—sarcoma	0.000302	0.000362	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—sarcoma	0.0003	0.00036	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—sarcoma	0.0003	0.00036	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—sarcoma	0.000299	0.000359	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—sarcoma	0.000298	0.000357	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—sarcoma	0.000297	0.000356	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—sarcoma	0.000295	0.000354	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—sarcoma	0.000294	0.000353	CcSEcCtD
Bexarotene—Decreased appetite—Epirubicin—sarcoma	0.00029	0.000349	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—sarcoma	0.000288	0.000346	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—sarcoma	0.000288	0.000346	CcSEcCtD
Bexarotene—Constipation—Epirubicin—sarcoma	0.000286	0.000343	CcSEcCtD
Bexarotene—Pain—Epirubicin—sarcoma	0.000286	0.000343	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000282	0.000338	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—sarcoma	0.00028	0.000336	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—sarcoma	0.000277	0.000333	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—sarcoma	0.000276	0.000331	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—sarcoma	0.000275	0.00033	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—sarcoma	0.000275	0.00033	CcSEcCtD
Bexarotene—Gastrointestinal pain—Epirubicin—sarcoma	0.000273	0.000328	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—sarcoma	0.000272	0.000327	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—sarcoma	0.000269	0.000323	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000267	0.00032	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—sarcoma	0.000266	0.00032	CcSEcCtD
Bexarotene—Pain—Doxorubicin—sarcoma	0.000264	0.000317	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—sarcoma	0.000264	0.000317	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—sarcoma	0.000264	0.000317	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—sarcoma	0.000264	0.000317	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—sarcoma	0.000255	0.000306	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—sarcoma	0.000253	0.000303	CcSEcCtD
Bexarotene—Hypersensitivity—Epirubicin—sarcoma	0.000246	0.000295	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—sarcoma	0.000244	0.000293	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—sarcoma	0.000244	0.000293	CcSEcCtD
Bexarotene—Asthenia—Epirubicin—sarcoma	0.00024	0.000288	CcSEcCtD
Bexarotene—Pruritus—Epirubicin—sarcoma	0.000236	0.000284	CcSEcCtD
Bexarotene—Diarrhoea—Epirubicin—sarcoma	0.000229	0.000274	CcSEcCtD
Bexarotene—Hypersensitivity—Doxorubicin—sarcoma	0.000228	0.000273	CcSEcCtD
Bexarotene—Asthenia—Doxorubicin—sarcoma	0.000222	0.000266	CcSEcCtD
Bexarotene—Dizziness—Epirubicin—sarcoma	0.000221	0.000265	CcSEcCtD
Bexarotene—Pruritus—Doxorubicin—sarcoma	0.000219	0.000262	CcSEcCtD
Bexarotene—Vomiting—Epirubicin—sarcoma	0.000212	0.000255	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—sarcoma	0.000211	0.000254	CcSEcCtD
Bexarotene—Rash—Epirubicin—sarcoma	0.000211	0.000253	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—sarcoma	0.00021	0.000253	CcSEcCtD
Bexarotene—Headache—Epirubicin—sarcoma	0.000209	0.000251	CcSEcCtD
Bexarotene—Dizziness—Doxorubicin—sarcoma	0.000204	0.000245	CcSEcCtD
Bexarotene—Nausea—Epirubicin—sarcoma	0.000198	0.000238	CcSEcCtD
Bexarotene—Vomiting—Doxorubicin—sarcoma	0.000196	0.000236	CcSEcCtD
Bexarotene—Rash—Doxorubicin—sarcoma	0.000195	0.000234	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—sarcoma	0.000195	0.000234	CcSEcCtD
Bexarotene—Headache—Doxorubicin—sarcoma	0.000194	0.000232	CcSEcCtD
Bexarotene—Nausea—Doxorubicin—sarcoma	0.000184	0.00022	CcSEcCtD
